CLYM
#2580
Climb Bio, Inc. - Common Stock
14.5 7 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.25%
Changement Mensuel
+17.59%
Evolution sur 6 mois
+113.01%
Changement Annuel
+166.36%
Clôture Précédente
15.0 6
Open
14.5 7
Low
14.5 7
High
14.5 7
Volume
95
Financials
- Market Capitalization 836.85 M
- Employee 29
- Founded 2018
- CEO N/A
- Website www.climbbio.com
- Headquarter Delaware, United States
- FIGI BBG00ZNKL0K6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.55
ratio cours/chiffre d'affaires
-932.13
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2528 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.05 USD | +0.06% | +0.35% | +1.13% | +18.82% | 885.21 M USD | ||
| 2551 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 46.48 USD | -0.81% | +1.86% | +20.70% | +54.26% | 868.24 M USD | ||
| 2582 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 8.10 USD | -0.98% | +1.50% | +29.81% | +175.51% | 833.51 M USD | ||
| 2596 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | +20.37% | -14.66% | 820.97 M USD |